NITI Aayog Vice-Chairman Ashok Kumar Lahiri released the eighth Trade Watch Quarterly, covering Q4 FY 2025-26 (January-March 2026), in New Delhi on 23 June 2026. Its theme is pharmaceutical trade.
India's total merchandise and services trade grew 5.4% in FY 2025-26 (April-March) to $1.84 trillion, with exports up 4.2% and imports up 6.5%.
In Q4, merchandise exports fell 2.8% to $112.03 billion while imports rose 11.9% to $195.5 billion; services exports rose 9% to $111.1 billion.
India exported about $35.8 billion of pharmaceutical and API products, against global import demand of about $1.3 trillion, a share of only 2.8%.
The report flags dependence on imported APIs and intermediates, mainly from China. It proposes a model pharmaceutical chapter for future FTAs and more bulk drug parks.
Government policy think tank set up on 1 January 2015 by a Union Cabinet resolution, replacing the Planning Commission; publishes Trade Watch Quarterly
Runs the bulk drug park scheme; under the Ministry of Chemicals and Fertilizers
Cut the cost of making bulk drugs (APIs) through common infrastructure, and so reduce import dependence
Key: Outlay Rs 3,000 crore (notified 2020); parks approved in Himachal Pradesh (Una), Gujarat (Bharuch) and Andhra Pradesh; central aid 90% for HP and 70% for the others, capped at Rs 1,000 crore per park. The report wants more such parks with common effluent treatment, zero liquid discharge and solvent recovery
Ease market access in regulated markets
Key: Regulatory reliance, GMP inspection, product registration, standards harmonisation and dispute resolution
GS Paper III > Indian Economy > External sector; Industrial policy (pharmaceuticals)
General Awareness > Economy > Reports and publications
Which state emerged as the poorest state in the first-ever Multi-dimensional Poverty Index (MPI) prepared by NITI Aayog (Nov 2021)?
Answer: Bihar
The Government of India has established NITI Aayog to replace the
Answer: Planning Commission
Atal Innovation Mission is set up under the
Answer: NITI Aayog
Who is the current CEO of NITI Aayog (as of the exam date)?
Answer: B.V.R. Subrahmanyam
As of 2023, who is the CEO of NITI Aayog?
Answer: B.V.R. Subrahmanyam
The biologically active component of a drug; India imports many APIs and key starting materials from China.
The raw chemical from which an API is synthesised.
Harmonised System code for retail medicaments, India's largest pharma export ($22.6 bn).